Gyebin Lee, Sangmin Lee, Yeung Bae Jin, Han-Na Kim, Joo Hyung Park, Hye Jin Cha
언어
영어(ENG)
URL
https://www.earticle.net/Article/A469862
※ 기관로그인 시 무료 이용이 가능합니다.
4,000원
원문정보
초록
영어
Hallucinations represent a transdiagnostic phenomenon observed in multiple neuropsychiatric disorders, including schizophrenia, substance use disorder and substance-induced psychotic conditions. Despite their clinical prevalence, objective assessment remains challenging due to its subjective nature, underscoring the critical need for validated translational models. The present study explores the biological mechanisms underlying hallucinations, evaluates the animal models developed to date, and discusses methods for analyzing these models along specific pathways. Hallucinations are primarily mediated through glutamatergic and/or serotonergic pathways. Numerous animal models for assessing hallucinations have been extensively reported; however, these models have mainly been designed to investigate specific neurotransmitter mechanisms, rather than encompassing all relevant pathways. Therefore, this study systematically examines currently established animal models based on the aforementioned neurotransmitter mechanisms and proposes future directions for developing universal animal models capable of comprehensively evaluating hallucinatory phenomena. The present study aims to provide deeper insights for future research involving animal models of hallucination.
목차
ABSTRACT INTRODUCTION NEURAL PATHWAYS ASSOCIATED WITH HALLUCINATIONS Serotonergic pathway Glutamatergic pathway DIRECT ASSESSMENT FOR EVALUATION OF HALLUCINATION IN ANIMAL MODEL Head twitch response (HTR) INDIRECT ASSESSMENTS FOR EVALUATION OF HALLUCINATION IN ANIMAL MODEL Pre-pulse inhibition (PPI) Open-field test (OFT) Stereotypy PUTATIVE UNIVERSAL ASSESSMENT OF HALLUCINATIONS Representation-mediated learning (RML) model CONCLUSION REFERENCES